Bottom Line The Path to $1 Trillion Current State (Nov 2025): Stock Price: ~$990 Market Cap: ~$885-930B Distance to $1T: ~7-13% away Catalysts Ahead: Orforglipron approval (March 2026 expected) Continued GLP-1 market expansion Kisunla (Alzheimer's) adoption ramp Pipeline readouts in oncology and immunology For Long-Term Investors: Volatility is part of the journey
Front Neurol 13:1095606 Thapaliya K, Marshall-Gradisnik S, Staines D, Barnden L (2021) Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
129 Korean Red Ginseng Korean red ginseng ( Panax ginseng , also known as Chinese or Asian ginseng) has been used in traditional herbal medicine throughout Asia to treat a broad range of health conditions including fatigue, stress, and age-related ailments
This suggests that, while bothersome, diarrhea is generally not severe enough to outweigh the benefits of the medication for most people
Benefits outlined on AgelessRx.com are based on 3rd party studies